Increased risk of second cancer among patients with ovarian borderline tumors

Gynecologic Oncology

Volumn 109, Issue 2, 2008, Pages 210-214

  Bouchardy, Christine ^a   Fernandez, Sarah ^a   Merglen, Arnaud ^a   Usel, Massimo ^a   Fioretta, Gérald ^a   Rapiti, Elisabetta ^a   Schubert, Hyma ^a   Pelte, Marie Françoise ^b   Chappuis, Pierre O ^c   Vlastos, Georges ^b  

^a GENEVA CANCER REGISTRY   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c Division of Medical Genetics   (Switzerland)

Author keywords

Borderline ovarian tumor; Cancer registry; Epidemiology; Risk factors; Second cancer

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CALCULATION; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; COLORECTAL CANCER; CONFIDENCE INTERVAL; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; OVARIAN BORDERLINE TUMOR; OVARY CANCER; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SECOND CANCER; SWITZERLAND;

ADULT; AGE FACTORS; AGED; BREAST NEOPLASMS; COHORT STUDIES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; OVARIAN NEOPLASMS; RISK ASSESSMENT;

EID: 42749090325     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.01.032     Document Type: Article

References (30)

1. Hankinson S.E., and Danforth K.N. Ovarian cancer. In: Schottenfeld D., and Fraumeni Jr. J.F. (Eds). Cancer epidemiology and prevention. 3 ed. (2006), Oxford University Press, New York 1013-1026
2. Shih I., and Kurman R.J. Molecular pathogenesis of ovarian borderline tumors: new insights and old challenges. Clin Cancer Res 11 (2005) 7273-7279
3. Gotlieb W.H., Chetrit A., Menczer J., et al. Demographic and genetic characteristics of patients with borderline ovarian tumors as compared to early stage invasive ovarian cancer. Gynecol Oncol 97 (2005) 780-783
4. Chapman W.B. Developments in the pathology of ovarian tumours. Curr Opin Obstet Gynecol 13 (2001) 53-59
5. Riman T., Dickman P.W., Nilsson S., et al. Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study. Gynecol Oncol 83 (2001) 575-585
6. Reimer R.R., Hoover R., Fraumeni Jr. J.F., and Young R.C. Second primary neoplasms following ovarian cancer. J Natl Cancer Inst 61 (1978) 1195-1197
7. Storm H.H., and Ewertz M. Second cancer following cancer of the female genital system in Denmark, 1943-80. Natl Cancer Inst Monogr 68 (1985) 331-340
8. Kaldor J.M., Day N.E., Band P., et al. Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries. Int J Cancer 39 (1987) 571-585
9. Shah S., Evans D.G., Blair V., Burnell L.D., and Birch J.M. Assessment of relative risk of second primary tumors after ovarian cancer and of the usefulness of double primary cases as a source of material for genetic studies with a cancer registry. Cancer 72 (1993) 819-827
10. Travis L.B., Curtis R.E., Boice Jr. J.D., et al. Second malignant neoplasms among long-term survivors of ovarian cancer. Cancer Res 56 (1996) 1564-1570
11. Bergfeldt K., Silfversward C., Einhorn S., and Hall P. Overestimated risk of second primary malignancies in ovarian cancer patients. Eur J Cancer 36 (2000) 100-105
12. Levi F., La Vecchia C., Randimbison L., and Te V.C. Borderline ovarian tumours in Vaud, Switzerland: incidence, survival and second neoplasms. Br J Cancer 79 (1999) 4-6
13. Casey A.C., Bell D.A., Lage J.M., et al. Epithelial ovarian tumors of borderline malignancy: long-term follow-up. Gynecol Oncol 50 (1993) 316-322
14. Bouchardy C. In: Parkin D.M., Whelan S.L., Ferlay J., Raymond L., and Young J. (Eds). Cancer incidence in five continents Vol. VII (1997), Lyon: International Agency for Research on Cancer 666-669 Switzerland, Geneva
15. ICD-O International classification of diseases for oncology. Geneva: World Health Organization; 1976.
16. Lee K.R., Tavassoli F.A., Prat J., et al. Surface epithelial-stromal tumours. In: Tavassoli F., and Devilee P. (Eds). World Health Organization classification of tumours. Pathology and genetics of tumours of the breast and female genital organs (2003), Lyon: International Agency for Research on Cancer 117-145
17. Staging classifications and clinical practice guidelines of gynecological cancers by the FIGO committee on gynecologic oncology (2000), Elsevier, Oxford
18. Breslow N.E., and Day N.E. Design considerations. Statistical methods in cancer research. Vol. I: The analysis of case-control studies (1980), Lyon: International Agency for Research on Cancer 271-333
19. Coleman M.P., Hermon C., and Douglas A. Person-years (PYRS). A Fortran program for cohort study analysis (1989), Lyon: International Agency for Research on Cancer IARC Internal Report. 89/006
20. Steenland K., Bray I., Greenland S., and Boffetta P. Empirical Bayes adjustments for multiple results in hypothesis-generating or surveillance studies. Cancer Epidemiol Biomarkers Prev 9 (2000) 895-903
21. Rothman K.J. No adjustments are needed for multiple comparisons. Epidemiology 1 (1990) 43-46
22. Perneger T.V. What's wrong with Bonferroni adjustments. BMJ 316 (1998) 1236-1238
23. McCluggage W.G., and Wilkinson N. Metastatic neoplasms involving the ovary: a review with an emphasis on morphological and immunohistochemical features. Histopathology 47 (2005) 231-247
24. Giovannucci E., and Wu K. Cancers of the colon and rectum. In: Schottenfeld D., and Fraumeni Jr. J. (Eds). Cancer epidemiology and prevention. 3 ed. (2006), Oxford University Press, New York 809-829
25. Colditz G.A., Baer H.J., and Tamimi R.M. Breast cancer. In: Schottenfeld D., and Fraumeni Jr. J. (Eds). Cancer epidemiology and prevention. 3 ed (2006), Oxford University Press, New York 995-1012
26. Beral V., and Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362 (2003) 419-427
27. Prat J., Ribe A., and Gallardo A. Hereditary ovarian cancer. Hum Pathol 36 (2005) 861-870
28. Watson P., Butzow R., Lynch H.T., et al. The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer. Gynecol Oncol 82 (2001) 223-228
29. Risch H.A., McLaughlin J.R., Cole D.E., et al. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 68 (2001) 700-710
30. Lakhani S.R., Manek S., Penault-Llorca F., et al. Pathology of ovarian cancers in BRCA1 and BRCA2 carriers. Clin Cancer Res 10 (2004) 2473-2481